D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
BHC holding history
Bausch Health Companies Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BHC overviewAll 13F holders of BHCFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,689,942
- Value
- $13.3M
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,689,942 | $13.3M | <0.1% | +2,068,187+332.6% | Added | Holders |
| Q1 2026 | 621,755 | $3.36M | <0.1% | −1,058,874−63.0% | Reduced | Holders |
| Q4 2025 | 1,680,629 | $11.7M | <0.1% | +748,012+80.2% | Added | Holders |
| Q3 2025 | 932,617 | $6.01M | <0.1% | +350,898+60.3% | Added | Holders |
| Q2 2025 | 581,719 | $3.88M | <0.1% | +33,840+6.2% | Added | Holders |
| Q1 2025 | 547,879 | $3.55M | <0.1% | +3,172+0.6% | Added | Holders |
| Q4 2024 | 544,707 | $4.39M | <0.1% | +248,871+84.1% | Added | Holders |
| Q3 2024 | 295,836 | $2.41M | <0.1% | −117,304−28.4% | Reduced | Holders |
| Q2 2024 | 413,140 | $2.88M | <0.1% | −918,746−69.0% | Reduced | Holders |
| Q1 2024 | 1,331,886 | $14.1M | <0.1% | +533,194+66.8% | Added | Holders |
| Q4 2023 | 798,692 | $6.41M | <0.1% | −1,078,232−57.4% | Reduced | Holders |
| Q3 2023 | 1,876,924 | $15.4M | <0.1% | −1,394,683−42.6% | Reduced | Holders |
| Q2 2023 | 3,271,607 | $26.2M | <0.1% | −1,356,903−29.3% | Reduced | Holders |
| Q1 2023 | 4,628,510 | $37.5M | 0.1% | −1,581,395−25.5% | Reduced | Holders |
| Q4 2022 | 6,209,905 | $39.0M | 0.1% | −2,018,023−24.5% | Reduced | Holders |
| Q3 2022 | 8,227,928 | $56.7M | 0.1% | +2,636,551+47.2% | Added | Holders |
| Q2 2022 | 5,591,377 | $46.7M | 0.1% | +4,611,318+470.5% | Added | Holders |
| Q1 2022 | 980,059 | $22.4M | <0.1% | +779,205+387.9% | Added | Holders |
| Q4 2021 | 200,854 | $5.55M | <0.1% | +200,854 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −160,491−100.0% | Sold out | Holders |
| Q2 2021 | 160,491 | $4.71M | <0.1% | +145,458+967.6% | Added | Holders |
| Q1 2021 | 15,033 | $477.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.